MedPath

STEMGEN

STEMGEN

Discontinued
DIN Number

02240229

Drug Class

Human

Market Date

Sep 20, 1999

Company
HC

biovitrum ab (publ)

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02240229
AIG Number0237442003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L03AA12 ANCESTIM
Product Specifications
Dosage FormPowder For Solution ,  Kit
Route of AdministrationSubcutaneous
AHFS Classification20:16.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

ANCESTIMActive
Strength: 1875 MCG / VIAL
Monograph: ANCESTIM
WATERActive
Strength: 5 ML / VIAL
Monograph: WATER

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.